Cargando…

The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing

Photodynamic therapy (PDT) has emerged as an effective treatment for various solid tumors. The transcription factor NRF2 is known to protect against oxidative and electrophilic stress; however, its constitutive activity in cancer confers resistance to anti-cancer drugs. In the present study, we inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Bo-hyun, Ryoo, In-geun, Kang, Han Chang, Kwak, Mi-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165896/
https://www.ncbi.nlm.nih.gov/pubmed/25226504
http://dx.doi.org/10.1371/journal.pone.0107158
_version_ 1782335157194194944
author Choi, Bo-hyun
Ryoo, In-geun
Kang, Han Chang
Kwak, Mi-Kyoung
author_facet Choi, Bo-hyun
Ryoo, In-geun
Kang, Han Chang
Kwak, Mi-Kyoung
author_sort Choi, Bo-hyun
collection PubMed
description Photodynamic therapy (PDT) has emerged as an effective treatment for various solid tumors. The transcription factor NRF2 is known to protect against oxidative and electrophilic stress; however, its constitutive activity in cancer confers resistance to anti-cancer drugs. In the present study, we investigated NRF2 signaling as a potential molecular determinant of pheophorbide a (Pba)-based PDT by using NRF2-knockdown breast carcinoma MDA-MB-231 cells. Cells with stable NRF2 knockdown showed enhanced cytotoxicity and apoptotic/necrotic cell death following PDT along with increased levels of singlet oxygen and reactive oxygen species (ROS). A confocal microscopic visualization of fluorogenic Pba demonstrated that NRF2-knockdown cells accumulate more Pba than control cells. A subsequent analysis of the expression of membrane drug transporters showed that the basal expression of BCRP is NRF2-dependent. Among measured drug transporters, the basal expression of breast cancer resistance protein (BCRP; ABCG2) was only diminished by NRF2-knockdown. Furthermore, after incubation with the BCRP specific inhibitor, differential cellular Pba accumulation and ROS in two cell lines were abolished. In addition, NRF2-knockdown cells express low level of peroxiredoxin 3 compared to the control, which implies that diminished mitochondrial ROS defense system can be contributing to PDT sensitization. The role of the NRF2-BCRP pathway in Pba-PDT response was further confirmed in colon carcinoma HT29 cells. Specifically, NRF2 knockdown resulted in enhanced cell death and increased singlet oxygen and ROS levels following PDT through the diminished expression of BCRP. Similarly, PDT-induced ROS generation was substantially increased by treatment with NRF2 shRNA in breast carcinoma MCF-7 cells, colon carcinoma HCT116 cells, renal carcinoma A498 cells, and glioblastoma A172 cells. Taken together, these results indicate that the manipulation of NRF2 can enhance Pba-PDT sensitivity in multiple cancer cells.
format Online
Article
Text
id pubmed-4165896
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41658962014-09-22 The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing Choi, Bo-hyun Ryoo, In-geun Kang, Han Chang Kwak, Mi-Kyoung PLoS One Research Article Photodynamic therapy (PDT) has emerged as an effective treatment for various solid tumors. The transcription factor NRF2 is known to protect against oxidative and electrophilic stress; however, its constitutive activity in cancer confers resistance to anti-cancer drugs. In the present study, we investigated NRF2 signaling as a potential molecular determinant of pheophorbide a (Pba)-based PDT by using NRF2-knockdown breast carcinoma MDA-MB-231 cells. Cells with stable NRF2 knockdown showed enhanced cytotoxicity and apoptotic/necrotic cell death following PDT along with increased levels of singlet oxygen and reactive oxygen species (ROS). A confocal microscopic visualization of fluorogenic Pba demonstrated that NRF2-knockdown cells accumulate more Pba than control cells. A subsequent analysis of the expression of membrane drug transporters showed that the basal expression of BCRP is NRF2-dependent. Among measured drug transporters, the basal expression of breast cancer resistance protein (BCRP; ABCG2) was only diminished by NRF2-knockdown. Furthermore, after incubation with the BCRP specific inhibitor, differential cellular Pba accumulation and ROS in two cell lines were abolished. In addition, NRF2-knockdown cells express low level of peroxiredoxin 3 compared to the control, which implies that diminished mitochondrial ROS defense system can be contributing to PDT sensitization. The role of the NRF2-BCRP pathway in Pba-PDT response was further confirmed in colon carcinoma HT29 cells. Specifically, NRF2 knockdown resulted in enhanced cell death and increased singlet oxygen and ROS levels following PDT through the diminished expression of BCRP. Similarly, PDT-induced ROS generation was substantially increased by treatment with NRF2 shRNA in breast carcinoma MCF-7 cells, colon carcinoma HCT116 cells, renal carcinoma A498 cells, and glioblastoma A172 cells. Taken together, these results indicate that the manipulation of NRF2 can enhance Pba-PDT sensitivity in multiple cancer cells. Public Library of Science 2014-09-16 /pmc/articles/PMC4165896/ /pubmed/25226504 http://dx.doi.org/10.1371/journal.pone.0107158 Text en © 2014 Choi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Choi, Bo-hyun
Ryoo, In-geun
Kang, Han Chang
Kwak, Mi-Kyoung
The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
title The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
title_full The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
title_fullStr The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
title_full_unstemmed The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
title_short The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
title_sort sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by nrf2 silencing
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165896/
https://www.ncbi.nlm.nih.gov/pubmed/25226504
http://dx.doi.org/10.1371/journal.pone.0107158
work_keys_str_mv AT choibohyun thesensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT ryooingeun thesensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT kanghanchang thesensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT kwakmikyoung thesensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT choibohyun sensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT ryooingeun sensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT kanghanchang sensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing
AT kwakmikyoung sensitivityofcancercellstopheophorbideabasedphotodynamictherapyisenhancedbynrf2silencing